Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Dunning

Showing results (111-120 of 357) with videos related to

Pageof 36
Sort By:
Frontiers in Oncology|November 20, 2020
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast CohortTim Rattay, Petra Seibold, Miguel E Aguado-Barrera, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2009
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort ConsortiumRuth C Travis, Fredrick Schumacher, Joel N Hirschhorn, et al.
Nature Communications|April 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patientsPhilipp Heumann, Miguel E Aguado-Barrera, Harkeran K Jandu, et al.
Journal of Medical Genetics|June 3, 2011
A role for XRCC2 gene polymorphisms in breast cancer risk and survivalWei-Yu Lin, Nicola J Camp, Lisa A Cannon-Albright, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic MutationsThomas U Ahearn, Parichoy Pal Choudhury, Andriy Derkach, et al.
Breast Cancer Research : BCR|December 10, 2016
Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestryWanqing Wen, Xiao-Ou Shu, Xingyi Guo, et al.
Human Molecular Genetics|August 1, 2013
A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer riskKaren A Pooley, Stig E Bojesen, Maren Weischer, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumSara Lindström, Jing Ma, David Altshuler, et al.
Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.
Pageof 36

Showing results (111-120 of 357) with videos related to

Sort By:
Pageof 36
Frontiers in Oncology|November 20, 2020
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast CohortTim Rattay, Petra Seibold, Miguel E Aguado-Barrera, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2009
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort ConsortiumRuth C Travis, Fredrick Schumacher, Joel N Hirschhorn, et al.
Nature Communications|April 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patientsPhilipp Heumann, Miguel E Aguado-Barrera, Harkeran K Jandu, et al.
Journal of Medical Genetics|June 3, 2011
A role for XRCC2 gene polymorphisms in breast cancer risk and survivalWei-Yu Lin, Nicola J Camp, Lisa A Cannon-Albright, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic MutationsThomas U Ahearn, Parichoy Pal Choudhury, Andriy Derkach, et al.
Breast Cancer Research : BCR|December 10, 2016
Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestryWanqing Wen, Xiao-Ou Shu, Xingyi Guo, et al.
Human Molecular Genetics|August 1, 2013
A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer riskKaren A Pooley, Stig E Bojesen, Maren Weischer, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumSara Lindström, Jing Ma, David Altshuler, et al.
Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.
Pageof 36